| Literature DB >> 35999446 |
Nicole Lange1, Thomas Stadtmüller2, Stefanie Scheibel2, Gerda Reischer2, Arthur Wagner2, Bernhard Meyer2, Jens Gempt2.
Abstract
Complications in spine surgery can arise in the intraoperative or the immediate postoperative period or in a delayed manner. These complications may lead to severe or even permanent morbidity if left undiagnosed and untreated. We prospectively interviewed 526 patients out of 1140 patients who consecutively underwent spinal surgery in our department between November 2017 and November 2018 and analysed the outcome and complication rates. A 12 months follow-up period was also adopted. We analysed the patients' clinical characteristics, comorbidities, surgical management, survival rates, and outcomes. Risk factor analyses for the development of complications were also performed. Patients' median age was 67 years (range: 13-96). The main diagnoses were as follows: degenerative in 50%, tumour in 22%, traumatic fractures in 13%, infections in 10%, reoperations in 3%, and others in 2%. Surgeries were emergency procedures (within 24 h) in 12%. Furthermore, 59% required instrumentation. The overall postoperative complication rate was 26%. Revision surgery was required in 12% of cases within 30 postoperative days (median time to revision 11 days [IQR 5-15 days]). The most frequent complications included wound healing disorders, re-bleeding, and CSF leakage. Thereby, the risk factor analysis revealed age-adjusted CCI (p = 0.01), metastatic tumour (p = 0.01), and atrial fibrillation (p = 0.02) as significant risk factors for postoperative complications. Additionally, postoperative KPS (p = 0.004), postoperative anaemia (p = 0.001), the length of hospital stay (p = 0.02), and duration of surgery (p = 00.002) were also identified as associated factors. Complication rates after spinal surgeries are still high, especially in patients with metastatic tumour disease and poor clinical status (KPS), requiring revision surgeries in several cases. Therefore, specific risk factors should be determined to carefully select surgery groups.Entities:
Mesh:
Year: 2022 PMID: 35999446 PMCID: PMC9399240 DOI: 10.1038/s41598-022-18417-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flowchart showing patient inclusion and exclusion throughout the study.
Demographic and clinical characteristics of patients.
| 67 | 13–96 | |
Distribution (no.; Percent) < 30 years | 20 | 4% |
| 30–39 years | 34 | 6% |
| 40–49 years | 40 | 8% |
| 50–59 years | 85 | 16% |
| 60–69 years | 123 | 23% |
| 70–79 years | 148 | 28% |
| ≥ 80 years | 76 | 14% |
| Female | 234 | 44% |
| Male | 292 | 56% |
| Degenerative | 262 | 50% |
| Tumour | 116 | 22% |
| Fracture/Trauma | 69 | 13% |
| Infection | 50 | 10% |
| Others | 12 | 5% |
| Hypertension | 227 | 43% |
| Diabetes | 80 | 15% |
| Smokers | 83 | 16% |
| Alcohol abuse | 78 | 15% |
| Metastatic tumour | 87 | 17% |
| Anticoagulant medication | 160 | 30% |
Complication rates in % according to their frequency.
| No | % (of all pat) | |
|---|---|---|
| CSF leakage | 19 | 3.6% |
| Injury of vertebral artery | 3 | 0.6% |
| Premature termination | 2 | 0.4% |
| Nerve root damage | 1 | 0.2% |
| Cement leakage | 1 | 0.2% |
| Surgical | ||
| Rebleeding | 16 | 3.0% |
| Wound healing disorder | 11 | 2.1% |
| Motor deficit | 10 | 1.9% |
| CSF leakage | 10 | 1.9% |
| Screw mispositioning | 7 | 1.3% |
| Abscess/spondylodiscitis | 6 | 1.1% |
| New dysesthesia | 6 | 1.1% |
| New back pain | 5 | 1.0% |
| New leg pain | 4 | 0.8% |
| Persistent stenosis | 4 | 0.8% |
| Material failure | 4 | 0.8% |
| Systemic | ||
| Urinary tract infection | 13 | 2.5% |
| Pneumonia | 7 | 1.3% |
| Cardiac event | 6 | 1.1% |
| Pulmonary embolism | 6 | 1.1% |
| Renal insufficiency | 3 | 0.6% |
| Blood stream infection | 3 | 0.6% |
| Dysphagia | 3 | 0.6% |
| Psychiatric disorders | 3 | 0.6% |
| Other | 8 | 1.5% |
Significant values are in [bold].
Risk factor analysis.
| Intraoperative complications | Postoperative complications | Revision surgeries | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | IQR | p | sig | OR | IQR | p | sig | OR | IQR | p | sig | |
| Age | 0.99 | 0.97–1.01 | 0.41 | ns | 1.01 | 1.00–1.03 | 0.07 | ns | 1.00 | 0.98 –1.02 | 0.91 | ns |
| BMI | 0.99 | 0.93 –1.05 | 0.77 | ns | 1.02 | 0.98 –1.05 | 0.43 | ns | 1.07 | 1.02 –1.13 | ||
| ASA score | 0.80 | 0.47 –1.36 | 0.41 | ns | 0.99 | 0.70 –1.38 | 0.93 | ns | 0.94 | 0.58 –1.52 | 0.80 | ns |
| KPS postoperative | 0.17 | 0.01 –4.60 | 0.29 | ns | 0.03 | 0.00 –0.81 | 0.91 | 0.02 –43.60 | 0.96 | ns | ||
| KPS preoperative | 1.73 | 0.02 –161 | 0.81 | ns | 21.43 | 0.45 –1016 | 0.12 | ns | 0.11 | 0.00 –12.20 | 0.36 | ns |
| mRS postoperative | 0.66 | 0.34 –1.27 | 0.21 | ns | 1.39 | 0.78 –2.48 | 0.26 | ns | 1.78 | 0.83 –3.83 | 0.14 | ns |
| mRS preoperative | 1.90 | 0.92 –3.93 | 0.08 | ns | 0.88 | 0.48 –1.60 | 0.67 | ns | 0.61 | 0.27 –1.37 | 0.23 | ns |
| Charlson Index | 0.96 | 0.73–1.27 | 0.79 | ns | 0.90 | 0.74–1.09 | 0.27 | ns | 1.09 | 0.85–1.40 | 0.51 | ns |
| Charlson Index age-adjusted | 1.03 | 0.81–1.30 | 0.82 | ns | 1.17 | 0.99–1.39 | 0.98 | 0.78–1.22 | 0.83 | ns | ||
| Diagnosis count | 0.91 | 0.75–1.09 | 0.30 | ns | 1.02 | 0.91–1.13 | 0.75 | ns | 1.10 | 0.95–1.26 | 0.20 | ns |
| Depression | χ2 = 1.71 | 0.19 | ns | χ2 = 0.15 | 0.70 | ns | χ2 = 0.87 | 0.35 | ns | |||
| Tumour with metastases | χ2 = 0.05 | 0.82 | ns | χ2 = 6.21 | χ2 = 4.75 | |||||||
| Atrial fibrillation | χ2 = 0.44 | 0,51 | ns | χ2 = 5.67 | χ2 = 2.14 | 0.14 | ns | |||||
| Creatinine pre-OP | 0.15 | 0.02–0.90 | 1.04 | 0.95–1.15 | 0.36 | ns | 0.46 | 0.14–1.47 | 0.19 | ns | ||
| GFR pre-OP | 0.98 | 0.96–1.00 | 0.08 | ns | 0.99 | 0.98–1.00 | 0.06 | ns | 0.99 | 0.97–1.00 | 0.10 | ns |
| CRP pre-OP | 1.02 | 0.97–1.06 | 0.49 | ns | 1.02 | 0.99–1.05 | 0.30 | ns | 1.03 | 0.99–1.07 | 0.10 | ns |
| Quick pre-OP | 0.98 | 0.96–1.01 | 0.12 | ns | 0.99 | 0.97–1.01 | 0.30 | ns | 0.98 | 0.96–1.00 | ||
| PTT pre-OP | 0.98 | 0.90–1.07 | 0.70 | ns | 0.98 | 0.93–1.04 | 0.51 | ns | 0.99 | 0.92–1.06 | 0.81 | ns |
| Platelets pre-OP | 1.00 | 1.00–1.00 | 0.64 | ns | 1.00 | 1.00–1.00 | 0.19 | ns | 1.00 | 1.00–1.00 | 0.49 | ns |
| Haemoglobin post OP | 0.92 | 0.76–1.12 | 0.43 | ns | 0.81 | 0.71–0.92 | 0.95 | 0.80–1.12 | 0.55 | ns | ||
| Haemoglobin pre-OP | 1.09 | 0.89–1.33 | 0.42 | ns | 1.20 | 1.05–1.37 | 1.11 | 0.93–1.33 | 0.23 | ns | ||
| Duration of surgery | 1.00 | 1.00–1.01 | 1.00 | 1.00–1.01 | 1.00 | 1.00–1.01 | 0.20 | ns | ||||
| Spinal levels of surgery | 1.32 | 0.97–1.81 | 0.08 | ns | 0.73 | 0.56–0.97 | 0.68 | 0.50–0.92 | ||||
| Blood loss | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | 0.81 | ns | 1.00 | 1.00–1.00 | ||||
| Instrumentation | 2.00 | 0.44–9.15 | 0.37 | ns | 1.25 | 0.43–3.60 | 0.68 | ns | 1.06 | 0.42–2.70 | 0.90 | ns |
| Use of cement | 0.70 | 0.16–3.06 | 0.64 | ns | 0.95 | 0.29–3.17 | 0.93 | ns | 0.95 | 0.30–2.98 | 0.92 | ns |
| Discharge not home | 0.60 | 0.30–1.23 | 0.16 | ns | 1.16 | 0.75–1.82 | 0.50 | ns | 0.96 | 0.63–1.46 | 0.86 | ns |
| Length of stay | 1.03 | 0.99–1.07 | 0.17 | ns | 1.05 | 1.01–1.09 | 1.03 | 1.01–1.05 | ||||
| Transfusion count | 1.06 | 0.65–1.73 | 0.82 | ns | 0.82 | 0.55–1.23 | 0.35 | ns | 1.22 | 0.86–1.72 | 0.27 | ns |
Significant values are in [bold].
Figure 2Significant risk factors for complications during patients’ hospital stay.